TPG (NASDAQ:TPG) 주식

TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.

Deal Dispatch

Commodities

Exclusives

Interview

AMCR

BERY

BMWYY

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

GOOG

GOOGL

KRON

MEIP

NISTF

PARA

SAVE

SBUX

SHEL

TSX:SGO

ULCC

VWAGY

새로이 등장한 블록 스타벅스(NASDAQ:SBUX)가 중국 사업의 일부 지분을 매각하려고 한다. 최근 1분기 중국 내 동일 매장 매출이 14% 감소하면서, 시애틀에 본사를 둔 이 커피 소매업체는 치열한 경제적 및 경쟁적 압박에 적응하기 위한 파트너십을 모색하고 있다.

딜 디스패치: 스타벅스 중국 사업 매각 고려, 노스볼트 파산, 다윈 파이낸셜이 광업에 대해 논의

AAUKF

APTV

ATSG

FFIV

PARIS:SGO

ROIC

SLGWF

SLNG

TRIP

새로 등장한 블록 에볼런트 헬스(NYSE:EVH)가 매물로 나온 것으로 알려졌다. 버지니아 주 알링턴에 본사를 둔 이 소프트웨어 회사는 인수 문의를 받은 후 경매 프로세스를 시작했다. 잠재적인 구혼자 중에는 TPG(NASDAQ:TPG), 클레이톤, 듀블리에 &amp; 라이스(Clayton, Dubilier &amp; Rice), KKR &amp; 컴퍼니(NYSE:KKR)가 있다. 로이터는 건강 보험사 엘레반스 헬스(NYSE:ELV)가 한 사모 펀드 파트너와 협력하여 거래를 추진할 수 있다고 보고했다.

딜 디스패치: 쉘, 유니레버 외에도 매각 뉴스; 어니언이 알렉스 존스의 인포워스 인수 등

TPG Inc

TPG Telecom Ltd

TOP GLOVE CORP BHD ORD by Top Glove Corp.

Top Glove Corp Bhd

TPG Inc. - 6.950% Fixed-Rate Junior Subordinated Notes due 2064

TPG RE Finance Trust Inc

TPG RE Finance Trust, Inc. 6.25% Series C Cumulative Redeemable Preferred Stock, $0.001 par value per share

WIIM

WOLF

Wolfspeed shares are trading lower amid reports that the company is preparing to file for bankruptcy within weeks.

Hedera Foundation CEO Charles Adkins said on Tuesday that integrating blockchain into social platforms will ensure transparent data handling and enable real‑time creator payments without centralized intermediaries.
In an interview with Benzinga, Adkins emphasized blockchain's capacity to enforce "trust and transparency" on social networks, particularly as governments introduce regulations requiring verifiable transaction histories and user‑data reporting.
"When regulatory regimes demand institutions submit transaction records or user data, a transparent, immutable ledger becomes essential," he said.
Adkins noted emerging privacy laws such as GDPR and forthcoming AI data‑protection rules will further elevate the need for cryptographically secured user consent and usage verification. "
You'll want to make sure your data is verified, used correctly and safeguarding consumers," he explained.
Asked about the U.S. regulatory landscape, Adkins welcomed recent clarity: "Regulation is moving in the right direction," he said, despite past governmental hesitancy over cryptocurrency's impact on fiat currencies. 
He observed that fear of undermining national currencies has slowed rule‑making but praised current momentum toward comprehensive guidelines.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45527096/bitcoin-whale-trader-up-over-20-million-in-unrealized-gains-on-700-million-btc-pepe-positions">Bitcoin Whale Trader Up Over $20 Million In Unrealized Gains On $700 Million BTC, Pepe Positions</a>
On blockchain's synergy with AI, Adkins argued that "AI actually pushes layer‑one blockchains to the forefront" by demanding provenance for training data and version control for evolving models. 
"Tokenizing each data input and embedding version control on‑chain ensures model integrity under future AI regulations," he said.
Addressing social media specifically, Adkins highlighted the unique fit of Hedera's low‑fee, deterministic‑finality Hashgraph: "Social platforms handle massive data flows and creator interactions requiring streaming micro‑payments. Only a predictable, fixed‑fee ledger can support real‑time tipping or content licensing at scale." 
He cited Hedera's participation in high‑profile TikTok acquisition bids as evidence of enterprise interest.
Adkins also touched on broader industry trends, noting that most new layer‑one chains lack sustainable use cases and that "general‑purpose blockchains launching today are often opportunistic rather than purposeful." 
He advocated industry‑wide standards, akin to early TCP/IP and HTTP protocols, to facilitate seamless cross‑chain interoperability and reduce "clunky" bridging.
Highlighting blockchain's transformative potential in developing economies: "Crypto and DeFi work best where ATMs don't. In volatile currencies, a stable token delivers predictability. For many users in South America, losing 10% of their paycheck daily, blockchain‑based stablecoins are life‑changing."
Read Next: • <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45526856/javier-milei-adjacent-meme-coin-no-longer-being-investigated-what-happened">Javier Milei-Adjacent Meme Coin No Longer Being Investigated: What Happened?</a>

Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

News

Social Media

Global

Hedera's Charles Adkins: Streaming Micro-Payments Could Transform How Creators Monetize Social Media

AMD stock has given up its prior gain. AMD shares were trading higher after Tesla CEO Elon Musk said Tesla expects to still buy GPUs from AMD and NVIDIA.

L3Harris Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) shares are rising in extended trading Tuesday after the Trump administration announced plans for a Golden Dome missile defense system that will involve <a href="https://www.benzinga.com/25/05/45149289/golden-dome-fever-lockheed-raytheon-northrop-brace-for-a-missile-defense-windfall">the company&#8217;s satellites</a>.
What Happened: President Donald Trump on Tuesday <a href="https://www.whitehouse.gov/live/">announced</a> the architecture for a $175 billion Golden Dome missile defense system has been decided upon.
Trump announced that Gen. Michael Guetlein will oversee the program, which is expected to be completed in less than three years. Trump also said a budget package that&#8217;s currently in the works will include&nbsp;an initial $25 billion to begin construction of the project. 
Trump noted that the system will feature &#8220;next-generation technologies &#8230; including space-based sensors and interceptors.&#8221;&nbsp;
Trump did not name any companies specifically, but Sen. Jim Banks (R-Ind.) said that L3Harris will be involved in manufacturing space satellites for the defense system, which sent shares higher after hours. He added that &#8220;a lot&#8221; of American companies will be involved in the project.
Trump noted that the system will be made entirely in the U.S., with big contributions from Alaska, Georgia and Indiana. The Trump administration also noted that the project will include some &#8220;new, defense-tech companies.&#8221;
&#8220;Rest assured, there will be nothing like this. Nobody else is capable of building it either,&#8221; Trump said. 
LHX Price Action: <a href="http://benzinga.com/quote/lhx">L3Harris shares</a> were up 2.03% after-hours, trading at $235.50 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45483220/money-spigot-thats-never-going-off-meta-reportedly-hiring-ex-pentagon-officials-as-they-target-defense-contracts">&#8216;Money Spigot That&#8217;s Never Going Off&#8217;—Meta Reportedly Hiring Ex-Pentagon Officials As They Target Defense Contracts</a></li>
</ul>
Photo: Shutterstock.

Government

SPACE

After-Hours Center

Movers

L3Harris Stock Moves Higher After Being Named In 'Golden Dome' Missile Defense System

Earnings

Earnings Misses

James Hardie Industries Q4 Adj. EPS $0.36, Inline, Sales $971.50M Miss $976.68M Estimate

Reborn Coffee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REBN#NASDAQ">REBN</a>) reported quarterly losses of $(0.47) per share. This is a 21.67 percent increase over losses of $(0.60) per share from the same period last year. The company reported $1.69 million in sales this quarter. This is a 11.53 percent increase over sales of $1.52 million the same period last year.

REBN

Reborn Coffee Q1 EPS $(0.47) Up From $(0.60) YoY, Sales $1.69M Up From $1.52M YoY

OSR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) reported quarterly losses of $(1.04) per share. The company reported $761.27 million in sales this quarter.

OSRH

OSR Holdings Q1 EPS $(1.04), Sales $761.27M

Bank of New York Mellon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) has outperformed the market over the past 5 years by 4.89% on an annualized basis producing an average annual return of 19.55%. Currently, Bank of New York Mellon has a market capitalization of $64.46 billion. 
Buying $1000 In BK: If an investor had bought $1000 of BK stock 5 years ago, it would be worth $2,611.59 today based on a price of $90.10 for BK at the time of writing.
<h3>Bank of New York Mellon's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747776628_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Toll Brothers Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) released its second-quarter results after Tuesday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/05/g45530143/toll-brothers-reports-fy-2025-second-quarter-results">from the quarter.</a>
The Details:&nbsp;Toll Brothers reported quarterly earnings of&nbsp;$3.50&nbsp;per share, which beat the analyst consensus estimate of&nbsp;$2.92&nbsp;by&nbsp;19.86%. Quarterly revenue came in at $2.71 billion,&nbsp;which beat the Street estimate of&nbsp;$2.48 billion. &nbsp;
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45524565/nvidias-1-trillion-comeback-shows-deepseek-no-longer-spooks-wall-street?utm_source=articleShare">Nvidia&#8217;s $1 Trillion Comeback Shows DeepSeek No Longer Spooks Wall Street&nbsp;</a>
For the second quarter, Toll Brothers reported: 
<ul class="wp-block-list">
<li>Home sales revenues were $2.71 billion, up 2% compared to last year&#8217;s second quarter; delivered homes were 2,899, up 10%.</li>
<li>Net signed contract value was $2.60 billion, down 11% compared to last year&#8217;s second quarter; contracted homes were 2,650, down 13%.</li>
<li>Backlog value was $6.84 billion at second quarter end, down 7% compared to last year&#8217;s second quarter; homes in backlog were 6,063, down 15%.</li>
<li>Adjusted home sales gross margin was 27.5%. </li>
</ul>
&#8220;We are pleased with our second quarter results, as we delivered earnings that significantly exceeded expectations. Despite a softer demand environment, we generated record second quarter home sales revenues of $2.71 billion, well above our guidance of $2.47 billion, and beat both our adjusted gross margin and SG&amp;A guidance,&#8221; said Douglas C. Yearley Jr., CEO of Toll Brothers.
TOL Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Toll Brothers stock was up 4.79% at $109.52 after-hours on Tuesday.  
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45506863/trumps-big-beautiful-bill-advances-heres-who-wins-and-loses?utm_source=articleShare">Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Advances: Here&#8217;s Who Wins And Loses&nbsp;</a></li>
</ul>
Photo: Shutterstock

Real Estate

Toll Brothers Shares Are Up After Strong Q2 Results: EPS Beat, Revenues Beat

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it successfully&nbsp;upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the "Notes"). The principal amount of the offering was increased from the previously announced offering size of $2,000,000,000 (equivalent). Teva expects to use the net proceeds from the offerings (i) to fund the announced tender offers (collectively, the "Tender Offer") to purchase, for cash, its 3.150% Senior Notes due 2026, 4.750% Sustainability-Linked Senior Notes due 2027, 3.750% Sustainability-Linked Senior Notes due 2027, 7.875% Sustainability-Linked Senior Notes due 2029, 7.375% Sustainability-Linked Senior Notes due 2029 and 8.125% Sustainability-Linked Senior Notes due 2031&nbsp;(as it may be amended prior to expiration thereof), (ii) to pay fees and expenses in connection therewith and (iii) to the extent of any remaining proceeds, the repayment of outstanding debt upon maturity, tender offer or earlier redemption. Net proceeds may be temporarily invested pending application for their stated purpose.
The Notes consist of (i) Teva Pharmaceutical Finance Netherlands II B.V's ("Teva Finance II") €1,000,000,000 aggregate principal amount of 4.125% EUR-denominated Senior Notes maturing in 2031, (ii) Teva Pharmaceutical Finance Netherlands III B.V.'s ("Teva Finance III") $500,000,000 aggregate principal amount of 6.000% USD-denominated Senior Notes maturing in 2032 and (iii) Teva Pharmaceutical Finance Netherlands IV B.V.'s ("Teva Finance IV" and, together with Teva Finance II and Teva Finance III, the "Issuers") $700,000,000 aggregate principal amount of 5.750% USD-denominated Senior Notes maturing in 2030.
The settlement of the Notes is expected to occur on or about May 28, 2025, subject to customary closing conditions. The settlement of the Notes will satisfy the financing condition to the Tender Offer.

Offerings

TEVA

Teva Pharmaceutical Industries Announces It Upsized Its Offering From $2B And Priced ~$2.3B Of Its Senior Notes

OSUR

Orasure Technologies Files For Mixed Shelf Of Up To $300M

General

Equus Total Return Receives NYSE Notice Of Non-Compliance With Minimum Share Price Requirement

Deupirfenidone 825 mg TID slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) to the range expected of healthy older adults over 6 months; new, preliminary open-label extension data support durability of this treatment effect over at least 52 weeks
Deupirfenidone 825 mg TID demonstrated a statistically significant benefit compared to placebo in delaying IPF progression
Detailed safety analysis underscores favorable tolerability profile for deupirfenidone
PureTech plans to meet with FDA before end of Q3 2025, with the goal of initiating a Phase 3 trial by year-end
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fpuretechhealth.com%2F&amp;esheet=54257865&amp;newsitemid=20250520345638&amp;lan=en-US&amp;anchor=PureTech+Health+plc&amp;index=1&amp;md5=d3c41ff08eb102e88d128b2fd110bddc">PureTech Health plc</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>, LSE: PRTC))) (&quot;PureTech&quot; or the &quot;Company&quot;), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, delivered a late-breaking, oral presentation at the 2025 American Thoracic Society (ATS) International Conference in San Francisco. The presentation provided further insights into the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.puretechhealth.com%2Fnews-releases%2Fnews-release-details%2Fpuretechs-deupirfenidone-lyt-100-slowed-lung-function-decline&amp;esheet=54257865&amp;newsitemid=20250520345638&amp;lan=en-US&amp;anchor=successful+Phase+2b+ELEVATE+IPF+trial&amp;index=2&amp;md5=df2f852b2e4793a012c9f61e73a222f2">successful Phase 2b ELEVATE IPF trial</a> of deupirfenidone (LYT-100), highlighting the strength and durability of deupirfenidone&#39;s treatment effect through at least 52 weeks while maintaining favorable tolerability in patients living with idiopathic pulmonary fibrosis (IPF).

Biotech

PRTC

PureTech Presents Phase 2b Data For Deupirfenidone At ATS 2025, Showing Statistically Significant Slowing Of IPF Progression With Durable Effect Over 52 Weeks, Favorable Safety Profile, And Plans For FDA Meeting And Phase 3 Trial Launch By End Of 2025

Insider Trades

BDSX

Biodesix Form4 Filing Shows Jack Schuler Bought 4,723,239 Shares Of Stock At An Average Price Of $0.28/Share

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 15 years by 4.05% on an annualized basis producing an average annual return of 16.13%. Currently, Aon has a market capitalization of $78.26 billion. 
Buying $100 In AON: If an investor had bought $100 of AON stock 15 years ago, it would be worth $934.58 today based on a price of $362.43 for AON at the time of writing.
<h3>Aon's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747775712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Aon 15 Years Ago Would Be Worth This Much Today

Shares of Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) are moving higher in Tuesday&#8217;s after-hours session after Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk announced that the company expects to purchase &#8220;a lot&#8221; of GPUs <a href="https://www.benzinga.com/news/25/04/44725803/musks-xai-aims-for-1-million-gpus-in-memphis-but-can-the-citys-grid-handle-a-27b-ai-power-surge">from the chip companies</a>.
What Happened: In an interview aired on CNBC&#8217;s &#8220;Closing Bell: Overtime,&#8221; Musk laid out a vision for the future that includes millions of fully autonomous robotaxi vehicles and Optimus bots. When asked how many GPUs the company will need to make that vision a reality, Musk said &#8220;quite a few.&#8221;
&#8220;We expect to still buy a lot of GPUs from Nvidia, some from AMD, and maybe from others,&#8221; Musk said. &#8220;As long as Nvidia is better than what we make, we&#8217;ll keep buying from Nvidia.&#8221;
Musk told CNBC that his vision is less than five years away. He also noted that his AI company xAI plans to continue buying GPUs from Nvidia. He highlighted the AI company&#8217;s training cluster, which he believes is the most powerful in the world right now, with over 200,000 GPUs at its facility in Memphis. 
Musk also told CNBC that xAI is in the process of building a second location that will feature one million Nvidia Blackwell GPUs, expected to be completed in the next six to nine months.
&#8220;It will be the first gigawatt-class training cluster in the world,&#8221; he said.
In after-hours at the time of publication on Tuesday, <a href="http://benzinga.com/quote/AMD">AMD shares</a> were up 0.77% at $114.38 and <a href="http://benzinga.com/quote/nvda">Nvidia shares</a> were narrowly higher, up 0.11% at $134.52 at last check, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Nvidia.

Tech

NVDA

TSLA

AMD, Nvidia Shares Jump After Musk Highlights xAI's GPU Needs: 'We Expect To Still Buy A Lot'

<a href="https://www.wsj.com/articles/wolfspeed-prepares-to-file-for-bankruptcy-within-weeks-7bd98040">https://www.wsj.com/articles/wolfspeed-prepares-to-file-for-bankruptcy-within-weeks-7bd98040</a>

' Wolfspeed Prepares to File for Bankruptcy Within Weeks'- WSJ

<h3>Gainers</h3>
<ul>
<li>Big 5 Sporting Goods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) shares moved upwards by 8.3% to $1.31 during Tuesday's after-market session. The company's market cap stands at $29.9 million. </li>
<li>Smith Douglas Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDHC#NYSE">SDHC</a>) shares moved upwards by 6.34% to $18.1. The market value of their outstanding shares is at $930.8 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>XWELL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XWEL#NASDAQ">XWEL</a>) stock rose 5.8% to $0.97. The market value of their outstanding shares is at $5.1 million. As per the news, the Q1 earnings report came out today. </li>
<li>Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) shares moved upwards by 5.63% to $110.4. The company's market cap stands at $11.0 billion. The company's, Q2 earnings came out today. </li>
<li>Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) shares moved upwards by 4.98% to $0.39. The company's market cap stands at $16.7 million. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Soho House (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHCO#NYSE">SHCO</a>) shares rose 4.81% to $6.75. The market value of their outstanding shares is at $1.3 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Neo-Concept International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) shares fell 17.6% to $0.35 during Tuesday's after-market session. The company's market cap stands at $7.1 million. </li>
<li>Outdoor Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) shares fell 12.16% to $1.59. The market value of their outstanding shares is at $188.8 million. </li>
<li>Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) shares decreased by 10.26% to $33.0. The company's market cap stands at $1.2 billion. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) shares fell 9.23% to $12.3. The market value of their outstanding shares is at $84.1 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) stock declined by 8.47% to $1.19. The company's market cap stands at $9.4 million. As per the news, the FY earnings report came out today. </li>
<li>AYRO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYRO#NASDAQ">AYRO</a>) stock fell 5.31% to $0.4. The company's market cap stands at $2.7 million. As per the press release, Q1 earnings came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AYRO

BGFV

LVLU

MTEN

POWW

SDHC

SHCO

XWEL

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock moved upwards by 39.5% to $0.38 during Tuesday's after-market session. The company's market cap stands at $55.3 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock rose 26.37% to $0.16. The company's, Q1 earnings came out 3 days ago. </li>
<li>MetaVia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTVA#NASDAQ">MTVA</a>) stock rose 15.6% to $0.81. The market value of their outstanding shares is at $8.2 million. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock rose 9.8% to $5.61. The market value of their outstanding shares is at $510.8 million. The company's, Q2 earnings came out 3 days ago. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) stock rose 7.23% to $0.44. The market value of their outstanding shares is at $12.1 million. </li>
<li>VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) stock increased by 6.7% to $0.52. The market value of their outstanding shares is at $53.9 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares fell 9.0% to $5.49 during Tuesday's after-market session. The market value of their outstanding shares is at $83.5 million. </li>
<li>HeartSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) shares declined by 6.46% to $4.2. The company's market cap stands at $4.5 million. </li>
<li>OptimizeRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRX#NASDAQ">OPRX</a>) stock fell 6.21% to $11.18. The company's market cap stands at $206.7 million. </li>
<li>HilleVax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLVX#NASDAQ">HLVX</a>) stock declined by 5.95% to $1.9. The company's market cap stands at $95.1 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 5.94% to $0.39. The company's market cap stands at $7.1 million. </li>
<li>Xtant Medical Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/XTNT#AMEX">XTNT</a>) stock decreased by 5.77% to $0.66. The market value of their outstanding shares is at $92.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HLVX

HSCS

INTS

MTVA

ONMD

OPRX

PTPI

VNRX

XTNT

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) stock moved upwards by 8.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $21.9 million. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) stock moved upwards by 6.58% to $0.42. The market value of their outstanding shares is at $5.2 million. </li>
<li>PS International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) shares rose 6.28% to $0.33. The company's market cap stands at $8.0 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) shares rose 5.73% to $3.22. The market value of their outstanding shares is at $109.8 million. </li>
<li>Freightos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGO#NASDAQ">CRGO</a>) shares rose 4.93% to $2.55. The company's market cap stands at $127.6 million. The company's, Q1 earnings came out today. </li>
<li>GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) stock rose 4.8% to $1.09. The company's market cap stands at $281.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Centuri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRI#NYSE">CTRI</a>) stock fell 8.6% to $17.92 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) stock fell 7.33% to $0.82. The market value of their outstanding shares is at $2.5 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>FBS Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) shares fell 7.0% to $0.65. The market value of their outstanding shares is at $8.7 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock decreased by 6.78% to $0.16. The company's market cap stands at $22.8 million. </li>
<li>Lakeside Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) stock declined by 5.95% to $0.95. The market value of their outstanding shares is at $7.1 million. As per the press release, Q3 earnings came out 3 days ago. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock fell 5.01% to $0.87. The company's market cap stands at $17.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRGO

CTRI

DXST

FBGL

NEOV

PSIG

SFHG

UGRO

XPON

12 Industrials Stocks Moving In Tuesday's After-Market Session

Press Releases

TPG and Temasek Join TA to Bolster Cliffwater's Continued Expansion

Sabre enters into definitive agreement to sell its Hospitality Solutions business unit to TPG for $1.1 billion

TPG RE Finance Trust, Inc. Reports Operating Results for the Quarter Ended March 31, 2025

TPG Launches Dedicated Sports Investing Business

TPG to Acquire Peppertree Capital Management

AvidXchange Agrees to be Acquired by TPG in Partnership with Corpay for $2.2 Billion

TPG Reports First Quarter 2025 Results

Legal

Johnson Fistel Investigates Fairness of Proposed Sale of AvidXchange Holdings to TPG Inc.

AVIDXCHANGE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AvidXchange Holdings, Inc. - AVDX

Comments

TPG

뉴스

파트너 / 기고자

벤징가 글로벌